Adalimumab to treat noninfectious pediatric chronic anterior uveitis: a case series
We found that ADA is effective in controlling inflammation, reducing the need for topical corticosteroids, and maintaining visual acuity in pCAU. There appears to be racial differences in African American children who had worse baseline disease and poorer outcomes. Studies are necessary to understand better and address these disparities.
Authors
- Hazem M. Mousa (ORCID: https://orcid.org/0000-0003-4213-7358)
- Ailin Song (ORCID: https://orcid.org/0000-0001-8451-054X)
- Nadim S. Azar (ORCID: https://orcid.org/0009-0004-3544-7184)
- Raul E. Ruiz‐Lozano (ORCID: https://orcid.org/0000-0001-7022-2395)
- C. Egla Rabinovich
- Daliya Dzhaber (ORCID: https://orcid.org/0000-0002-6468-884X)
- Matias Soifer (ORCID: https://orcid.org/0000-0002-8695-2541)
- Sofia Murillo (ORCID: https://orcid.org/0000-0002-8406-2318)
- Manuel E. Quiroga-Garza (ORCID: https://orcid.org/0000-0002-5237-240X)
- Victor L. Perez (ORCID: https://orcid.org/0000-0002-2983-0847)
Institutions
- University of Miami (US)
- Duke University (US)
- University of California, San Francisco (US)
- Duke University Health System (US)
Publication Details
- Journal
- International Ophthalmology
- Published
- 2024-09-10
- DOI
- https://doi.org/10.1007/s10792-024-03289-1
- Citations
- 2
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 1.08